Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI

被引：0
|
作者：
So, Kwang Sup [1 ]
Choi, Yun Jung [1 ]
Kim, Sun Ye [1 ]
Choi, Chang-Min [1 ]
Lee, Jae Cheol [1 ]
Kim, Woo Sung [1 ]
Rho, Jin Kyung [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4443
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
    Uramoto, Hidetaka
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Kuwano, Michihiko
    Ono, Mayumi
    LUNG CANCER, 2011, 73 (03) : 361 - 365
  • [2] Advances in the management of acquired resistance to EGFR-TKI in non-small cell lung cancer
    Fei Zhou
    Caicun Zhou
    Oncology and Translational Medicine, 2015, 1 (01) : 20 - 25
  • [3] REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Yamauchi, Hiroyoshi
    Nakayama, Masayuki
    Yamamoto, Shinichi
    Saito, Tatsuya
    Okuyama, Akiko
    Mato, Naoko
    Yamasawa, Hideaki
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2017, 22 : 242 - 242
  • [4] Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance
    Lee, Jeong Eun
    Park, Hee Sun
    Lee, Dahye
    Yoo, Geon
    Kim, Tackhoon
    Jeon, Haeyon
    Yeo, Min-Kyung
    Lee, Choong-Sik
    Moon, Jae Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    Park, Dong Il
    Park, Yeon Hee
    Lee, Jae Cheol
    Oh, In-Jae
    Lim, Dae Sik
    Chung, Chaeuk
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 474 (01) : 154 - 160
  • [5] Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
    Da Hyun Kang
    Sung Soo Jung
    Min-Kyung Yeo
    Da Hye Lee
    Geon Yoo
    Sang Yeon Cho
    In-Jae Oh
    Ju-Ock Kim
    Hee Sun Park
    Chaeuk Chung
    Jeong Eun Lee
    BMC Cancer, 20
  • [6] Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
    Kang, Da Hyun
    Jung, Sung Soo
    Yeo, Min-Kyung
    Lee, Da Hye
    Yoo, Geon
    Cho, Sang Yeon
    Oh, In-Jae
    Kim, Ju-Ock
    Park, Hee Sun
    Chung, Chaeuk
    Lee, Jeong Eun
    BMC CANCER, 2020, 20 (01)
  • [7] Molecular mechanism of transformation from adenocarcinoma to small-cell lung cancer after EGFR-TKI
    Han, J.
    Zhang, Q.
    Wang, B.
    Zhou, Q.
    Zhang, Z.
    Chuai, S.
    Yang, J-J.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI
    Han, Jiefei
    Zhang, Qiuyi
    Wang, Binchao
    Zhou, Qing
    Yan, Lixu
    Zhang, Zhou
    Chen, Huajun
    Su, Jian
    Xie, Zhi
    Niu, Feiyu
    Wu, Yi Long
    Chuai, Shannon
    Yang, Jinji
    Dong, Zhong-Yi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S240 - S241
  • [9] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] Autophagy facilitates the EGFR-TKI acquired resistance of non-small-cell lung cancer cells
    Liu, Donglei
    Yang, Yang
    Zhao, Song
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (03) : 141 - 142
12345